Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Genentech | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Genentech

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Genentech, Inc. has made two vice president appointments: Michael P. Miller to vice president, sales and marketing, HER Family; and David Schenkein, M.D., to vice president, clinical hematology/oncology. Mr. Miller is replacing John Orwin who was promoted to vice president, BioOncology.

Mr. Miller will be responsible for leading all sales and marketing activities for Herceptin and Tarceva and will report to Mr. Orwin. He joins the company from Connetics Corp., where he was senior vice president, chief commercial officer and led the commercial activities for the company’s medical dermatology businesses. Mr. Miller has more than 25 years of pharmaceutical sales and marketing experience and has held various commercial leadership roles with Alza Corp., Vivus Corp. and Syntex Laboratories.

Mr. Schenkein will be responsible for leading the medical and scientific strategies for the Development BioOncology portfolio, as well as overseeing the BioOncology Clinical Science and Medical Science Liaison functions. Genentech’s BioOncology marketed products include Avastin, Herceptin, Rituxan, and Tarceva. He will report to Hal Barron, M.D., senior vice president, development, and chief medical officer. He joins the company from Millennium Pharmaceuticals, where he held several executive leadership positions, including most recently, senior vice president of clinical research. Prior to his positions at Millennium, he spent 18 years in academic/clinical medicine. Additionally, Mr. Schenkein is an associate professor of Medicine at Tufts University School of Medicine.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters